PROVIDENCE – Rhode Island medical-device maker Ximedica announced last week that it has relocated its Hong Kong headquarters to the Hong Kong Science and Technology Park, a “world-class hub for innovation and technology in the heart of the city’s biotech industry.”
Relocating to the Hong Kong Science and Technology Park is a strategic move for Ximedica, the company said in a statement. It allows access to advanced research, testing and manufacturing facilities. The park will host the company’s surgical, stem-cell harvesting, wound-management, drug-delivery and respiratory-device research and development activities, as well as office space for its employees.
“Our new location gives us access not only to state-of-the-art facilities needed to develop medical and diagnostic products of the future in the fast-growing China market, but similarly an opportunity to forge collaborations with a network of partners from around the world,” Michael Pereira, Ximedica vice president of program development and engineering, said in the statement. •